Financial reports
10-Q
2003 Q1
Quarterly report
14 May 03
10-K
2002 FY
Annual report
24 Mar 03
10-Q
2002 Q3
Quarterly report
14 Nov 02
10-Q
2002 Q2
Quarterly report
14 Aug 02
10-Q
2002 Q1
Quarterly report
1 May 02
10-K
2001 FY
Annual report
29 Mar 02
10-Q
2001 Q3
Quarterly report
14 Nov 01
10-Q
2001 Q2
Quarterly report
14 Aug 01
10-Q
2001 Q1
Quarterly report
14 May 01
10-K405
2000 FY
Annual report (delinquent filer disclosure)
22 Mar 01
Current reports
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
8-K
Other events
23 Jun 03
8-K
Financial statements and exhibits
22 Apr 03
8-K
Other events
4 Mar 03
8-K
Other events
20 Feb 03
8-K
Inverness Medical Innovations and Ostex International Provide Merger Update
2 Jan 03
8-K
Inverness Medical Innovations to Acquire Ostex International
10 Sep 02
8-K/A
Changes in registrant's certifying accountant
11 Jun 02
8-K/A
Changes in registrant's certifying accountant
7 Jun 02
8-K
Changes in registrant's certifying accountant
30 May 02
Registration and prospectus
424B3
Prospectus supplement
13 Dec 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
424B3
Prospectus supplement
23 Apr 10
POSASR
Automatic shelf registration (post-effective amendment)
29 Mar 10
S-4
Registration of securities issued in business combination transactions
12 Feb 10
D
$100M in debt / Subsidiary Guarantees, sold $100M, 3 investors
13 Oct 09
Proxies
DEF 14A
Definitive proxy
28 Mar 02
DEF 14A
Definitive proxy
22 Mar 01
DEF 14A
Definitive proxy
30 Mar 00
DEF 14A
Definitive proxy
15 Apr 99
DEF 14A
Definitive proxy
3 Apr 98
DEF 14A
Definitive proxy
25 Apr 97